ES2079653T3 - Metodos para determinar anticuerpos antifosfolipidos. - Google Patents

Metodos para determinar anticuerpos antifosfolipidos.

Info

Publication number
ES2079653T3
ES2079653T3 ES91907571T ES91907571T ES2079653T3 ES 2079653 T3 ES2079653 T3 ES 2079653T3 ES 91907571 T ES91907571 T ES 91907571T ES 91907571 T ES91907571 T ES 91907571T ES 2079653 T3 ES2079653 T3 ES 2079653T3
Authority
ES
Spain
Prior art keywords
sample
antiphospholipid antibodies
determining whether
antibodies
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91907571T
Other languages
English (en)
Inventor
Steven Anthony Krilis
Hugh Patrick Mcneill
Colin Nicholson Chesterman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamasa Shoyu KK
Original Assignee
Yamasa Shoyu KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamasa Shoyu KK filed Critical Yamasa Shoyu KK
Application granted granted Critical
Publication of ES2079653T3 publication Critical patent/ES2079653T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

SE PRESENTA UN METODO PARA DETERMINAR LA PRESENCIA DE ANTICUERPOS ANTIFOSFOLIPIDOS EN UNA MUESTRA. EL METODO CONSISTE EN CONTACTAR LA MUESTRA CON UN FOSFOLIPIDO DE CARGA NEGATIVA CON UNA (BETA)-2-GLICOPROTEINA -I O UN HOMOLOGO O ANALOGO DE LA MISMA Y DETERMINAR SI ALGUN ANTIFOSFOLIPIDO SE HA UNIDO AL FOSFOLIPIDO Y (BETA)-2-GLICOPROTEINA-I CONTACTADOS, EN LA QUE LA DETECCION DE LA UNION DE ANTICUERPOS ANTIFOSFOLIPIDOS AL FOSFOLIPIDO Y (BETA)-2-GLICOPROTEINA-I ES INDICADORA DE LA PRESENCIA DE ANTICUERPOS ANTIFOSFOLIPIDOS EN LA MUESTRA. TAMBIEN SE PRESENTA UN METODO PARA DETERMINAR LA PRESENCIA DE UN FOSFOLIPIDO DE CARGA NEGATIVA EN UNA MUESTRA, UN EQUIPO PARA SU UTILIZACION EN UN ENSAYO PARA DETERMINAR LA PRESENCIA DE ANTICUERPOS ANTIFOSFOLIPIDOS EN UNA MUESTRA, UN EQUIPO PARA UTILIZAR EN UN ENSAYO PARA DETERMINAR LA PRESENCIA DE UN FOSFOLIPIDO DE CARGA NEGATIVA EN UNA MUESTRA, UN METODO PARA DETERMINAR SI LOS ANTICUERPOS ANTIFOSFOLIPIDOS DE UNA MUESTRA SON ANTICUERPOS DE UNA ENFERMEDAD AUTOINMUNE Y SI HAY ANTICUERPOS ANTIFOSFOLIPIDOS DE UNA ENFERMEDAD INFECCIOSA EN LA MUESTRA.
ES91907571T 1990-04-06 1991-04-04 Metodos para determinar anticuerpos antifosfolipidos. Expired - Lifetime ES2079653T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPJ954990 1990-04-06
AUPK218690 1990-09-07

Publications (1)

Publication Number Publication Date
ES2079653T3 true ES2079653T3 (es) 1996-01-16

Family

ID=25643843

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91907571T Expired - Lifetime ES2079653T3 (es) 1990-04-06 1991-04-04 Metodos para determinar anticuerpos antifosfolipidos.

Country Status (8)

Country Link
US (1) US5344758A (es)
EP (1) EP0474849B1 (es)
JP (1) JPH0688823A (es)
AT (1) ATE127925T1 (es)
CA (1) CA2058769C (es)
DE (1) DE69112966T2 (es)
ES (1) ES2079653T3 (es)
WO (1) WO1991015772A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002012903A1 (es) * 2000-08-04 2002-02-14 Escuela Nacional De Ciencias Biologicas Del I.P.N. Metodos para el diagnostico y/o tratamiento de enfermedades relacionadas con anticuerpos antifosfolipidos, y dispositivos utilizados

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991006006A1 (en) * 1989-10-19 1991-05-02 Yamasa Shoyu Kabushiki Kaisha Carrier for binding antiphospholipid antibody, immunoassay using the same, and kit therefor
AU666352B2 (en) * 1992-02-05 1996-02-08 Takao Koike Solid-phase reagent and assay method for measuring antibodies specific to antiphospholipid syndrome
CA2072548A1 (en) * 1992-06-26 1993-12-27 Michael W. Stewart Methods for determining antiphospholipid antibodies
WO1995009363A1 (en) 1993-09-29 1995-04-06 Yamasa Corporation Method of assaying oxidized lipoprotein and application thereof
CA2176007A1 (en) * 1993-11-16 1995-05-26 Eiji Matsuura Method of assaying antiphospholipid antibody and kit therefor
JP3370786B2 (ja) * 1994-07-25 2003-01-27 鐘淵化学工業株式会社 自己抗体の免疫学的測定法
WO1996004559A1 (fr) * 1994-08-01 1996-02-15 Institut Français De Recherches Scientifiques Pour Le Developpement En Cooperation - Orstom Procede de separation et/ou de detection et/ou de quantification de compose(s) infectieux et support pour la mise en ×uvre du procede
US6410775B1 (en) * 1995-06-07 2002-06-25 La Jolla Pharmaceutical Company APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies
US5874409A (en) * 1995-06-07 1999-02-23 La Jolla Pharmaceutical Company APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies
US6017721A (en) * 1995-10-18 2000-01-25 The United States Of America As Represented By The Department Of Health And Human Services Chromatographic method and device for preparing blood serum for compatibility testing
US5776487A (en) * 1996-04-19 1998-07-07 Pasteur Sanofi Diagnostics Liposome reagents for immunoassays
US5780319A (en) * 1996-04-19 1998-07-14 Pasteur Sanofi Diagnostics Immunoassays to detect antiphospholipid antibodies
KR20000016414A (ko) * 1996-06-06 2000-03-25 와이즈먼 앤드루 Apl 면역반응성 펩티드, 그것의 콘주게이트 및 apl항체-매개병변의 치료방법
US6177282B1 (en) * 1997-08-12 2001-01-23 Mcintyre John A. Antigens embedded in thermoplastic
US6858210B1 (en) 1998-06-09 2005-02-22 La Jolla Pharmaceutical Co. Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same
US6818213B1 (en) 1998-07-13 2004-11-16 Board Of Regents, The University Of Texas System Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids
CA2333147C (en) 1998-07-13 2012-02-07 Board Of Regents, The University Of Texas System Cancer treatment methods using antibodies to aminophospholipids
US6406693B1 (en) 1998-07-13 2002-06-18 Board Of Regents, The University Of Texas System Cancer treatment methods using antibodies to aminophospholipids
US7067109B1 (en) 1998-07-13 2006-06-27 Board Of Regents, The University Of Texas System Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids
IL126447A (en) * 1998-10-04 2004-09-27 Vascular Biogenics Ltd An immune preparation that confers tolerance in oral administration and its use in the prevention and / or treatment of atherosclerosis
US20050197283A1 (en) * 1998-10-04 2005-09-08 Vascular Biogenics Ltd. Compositions containing beta 2-glycoprotein I for the prevention and/or treatment of vascular disease
US7361481B2 (en) * 1999-04-09 2008-04-22 Women's And Children's Hospital Diagnosis of lysosomal storage disorders using saposins and other markers
JP2001207584A (ja) 2000-01-31 2001-08-03 Nichiha Corp 着色建築板及びその製造方法
DE10018954B4 (de) * 2000-04-17 2007-07-19 Orgentec Diagnostika Gmbh Verwendung einer beschichteten Kunststoff-Festphase in einem Verfahren zur Bestimmung eines Analyten
GB0104057D0 (en) * 2001-02-20 2001-04-04 Babraham Inst Antiphospholipid antibody syndrome
KR100445939B1 (ko) * 2002-03-23 2004-08-25 강철훈 알루미늄 이온을 포함하는 단백질 염색용 처리용액 및 이를 이용한 단백질 염색방법
AU2003237870A1 (en) * 2002-06-07 2003-12-22 The Brigham & Women's Hospital, Inc. Method and composition for inhibing or slowing blood coagulation
US7771956B2 (en) * 2003-06-30 2010-08-10 Brigham & Women's Hospital, Inc. Method for detecting the presence of a phospholipid
CN101146826A (zh) * 2005-01-24 2008-03-19 得克萨斯大学体系董事会 与磷脂酰丝氨酸结合的fc融合构建体及其治疗用途
EP1874334A4 (en) * 2005-04-15 2011-03-30 Vascular Biogenics Ltd COMPOSITIONS WITH BETA 2-GLYCOPROTEIN I-PEPTIDES FOR THE PREVENTION AND / OR TREATMENT OF VASCULAR DISEASES
EP1872132B1 (en) * 2005-04-18 2013-09-18 Bio-Rad Laboratories, Inc. Solid phase immobilization of phospholipids and cofactor proteins via covalent attachment
FR2927171B1 (fr) * 2008-02-01 2010-03-19 Apoh Technollgies Sa Procede de detection et/ou de quantification et/ou d'identification in vitro de bacteries dans un materiau biologique
WO2013007570A1 (en) * 2011-07-12 2013-01-17 Centre National De La Recherche Scientifique Method for the high-speed screening of lipase activity and/or lipase inhibitors in biological samples and in culture media
CN116068172B (zh) * 2023-03-06 2023-06-20 苏州惠中生物科技有限公司 一种用于抗心磷脂抗体定量检测的磁微粒化学发光试剂及试剂盒

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002012903A1 (es) * 2000-08-04 2002-02-14 Escuela Nacional De Ciencias Biologicas Del I.P.N. Metodos para el diagnostico y/o tratamiento de enfermedades relacionadas con anticuerpos antifosfolipidos, y dispositivos utilizados

Also Published As

Publication number Publication date
EP0474849A4 (es) 1994-03-30
ATE127925T1 (de) 1995-09-15
US5344758A (en) 1994-09-06
DE69112966T2 (de) 1996-02-15
JPH0688823A (ja) 1994-03-29
DE69112966D1 (de) 1995-10-19
CA2058769A1 (en) 1991-10-07
WO1991015772A1 (en) 1991-10-17
CA2058769C (en) 1999-03-02
EP0474849B1 (en) 1995-09-13
EP0474849A1 (en) 1992-03-18

Similar Documents

Publication Publication Date Title
ES2079653T3 (es) Metodos para determinar anticuerpos antifosfolipidos.
ATE118275T1 (de) Immunoassayverfahren zum nachweis von antigenen.
BR8807567A (pt) Teste imuno-enzimatico simultaneo para a deteccao de antigeno e/ou anticorpo em humanos
ATE209356T1 (de) Ein verfahren zur bestimmung von kollagenfragmenten in körperflüssigkeiten, ein testkit und mittel zur durchführung des verfahrens, und seine verwendung zur feststellung von mit dem kollagenmetabolismus assoziierten störungen
FI886000L (fi) Immunologisia määritysmenetelmiä ja niissä käytettävä reagenssi
ES557802A0 (es) Un metodo cromatografico de afinidad para la determinacion de antigenos en liquidos biologicos
DE68905313D1 (de) Enzym-immunoassay zur messung des cyclosporin-a-spiegels in vollblut-proben.
IT1145374B (it) Procedimento per determinare un complesso di antigene od anticorpo e corredo di reagenti per esso
DE3889279D1 (de) Diagnostisches Mittel und Verfahren zur Bestimmung von Apolipoprotein B.
FI910324A7 (fi) Menetelmät ja testipakkaukset ihmisen leukosyyttiantigeeni-DNA:n havaitsemiseksi
ATE114817T1 (de) Immunologisches nachweisverfahren für herbizide.
ES539223A0 (es) Mejoras intruducidas en un ensayo para determinar un antigeno bacteriano en una muestra de ensayo
PT88303A (pt) Processo para a fixacao de um antigene ou anticorpo e de uma proteina imunologicamente diferente de um veiculo solido
DE3686717D1 (de) Immuntestverfahren.
DE3883808D1 (de) Testsatz, Extraktionsvorrichtung und Verfahren zur Bestimmung von Streptococcus-A-Antigen.
DE69132144D1 (de) Menschliche phospholipase aktivierender proteinteil
ATE60445T1 (de) Verfahren und testelement zum auffinden von zellaesionen.
ATE208040T1 (de) Immunoassay-reagenzien, testsätze und verfahren
DE3650635D1 (de) Monoklonale Antikörper
DE59808639D1 (de) Verfahren zur bestimmung von schilddrüsen-autoantikörpern
DE69526056D1 (de) Immunologisches Testverfahren zur Quantifizierung von PEG-modifiziertem humanem Granulozyten-Kolonie-Stimulierender-Faktor
EP0407605A4 (en) Reagent for detecting antibody corresponding to acid-fast bacterium antigen and application thereof
FI903504A7 (fi) Menetelmä antigeenien ja/tai vasta-aineiden määrittämiseksi ihmisen kehon nesteissä sekä menetelmän toteuttamiseksi tarkoitettu koesarja
FI901467A7 (fi) Analyysipakkaus ja -menetelmä kokonaisten solujen määritykseen
DE58907208D1 (de) Verfahren zur Bestimmung von Antikörpern.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 474849

Country of ref document: ES